National (Australia) HPV 3 dose vaccination coverage for females turning 15 years of age in 2014

State Estimated
Resident
Population
(as at
30/06/2014)
Coverage Dose 1 Coverage Dose 2 Coverage Dose 3 Total
Doses
n % n % n %
ACT 2,133 1,931 90.5% 1,848 86.6% 1,500 70.3% 5,279
NSW 43,829 34,973 79.8% 33,282 75.9% 30,951 70.6% 99,206
NT 1,521 1,414 93.0% 1,343 88.3% 1,227 80.7% 3,984
QLD 29,498 24,544 83.2% 23,660 80.2% 21,826 74.0% 70,030
SA 9,963 8,414 84.5% 8,090 81.2% 7,373 74.0% 23,877
TAS 3,281 2,689 82.0% 2,546 77.6% 2,245 68.4% 7,480
VIC 33,184 29,103 87.7% 27,925 84.2% 25,891 78.0% 82,919
WA 15,413 13,151 85.3% 12,797 83.0% 11,850 76.9% 37,798
NAT 138,822 116,219 83.7% 111,491 80.3% 102,863 74.1% 330,573


NOTES

  • Data extracted from the National HPV Vaccination Program Register (HPV Register) as at 12 JULY 2017 and includes females vaccinated between APR 2007 and JUN 2017.
  • Includes doses that comply with the recommended vaccine dosage and administration as per the Australian Immunisation Handbook (up to 3 doses administered at prescribed intervals).
  • Population is Estimated Resident Population (ERP) provided by the Australian Bureau of Statistics - CAT 3101.0 Australian Demographics Statistics, Tables 51 to 58 - Estimated Resident Population by Single Year of Age by State and Territory, REVISED data published DEC 2016.
  • Age is age as at date of ERP estimate (30th June).
  • Coverage is calculated as doses administered and reported to the HPV Register/Estimated Resident Population expressed as a percentage.
  • Excludes consumers who do not wish their details to be recorded on the HPV Register.
  • The National HPV Vaccination Program initially provided quadrivalent HPV vaccine for all females aged 12-26 years as at mid 2007 ( school program commenced April 2007 and GP/community program in July 2007) until end December 2009. From 2009 the Program offered HPV vaccination routinely to females in the first year of high school (usually at 12-13 years). From 2013, males were also offered HPV vaccination routinely in the first year of high school (age 12-13 years), with a catch-up program available for males aged 14-15 years in 2013 and 2014.
  • As the ages of students in the first year of high school varies between jurisdictions, age 15 is used as the age for routine review of vaccination coverage that provides the best comparison to allow for these varying ages in administration, as per World Health Organization (WHO) recommendations. The figure indicates that 15yo coverage is relatively stable nationally at around 71%.
  • HPV Vaccination doses administered through general practice and in other community settings may be incompletely notified to the HPV Register. The extent of under notification differs by jurisdiction, with the Northern Territory and Queensland expected to have the most complete notification, due to notification of doses via State based immunisation registers.